Related Experiment Video
Updated: Jan 3, 2026

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
Long non-coding RNA FENDRR restrains the aggressiveness of CRC via regulating miR-18a-5p/ING4 axis
Sheng Lu Yin1, Fei Xiao1, Yong Fu Liu1
1The Department of the Emergency Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Abstract:
There is increasing evidence has indicated that long non-coding RNAs (lncRNAs) are implicated in the tumorigenesis and development of colorectal cancer (CRC). Nevertheless, the clinical significances and functions of FENDRR in CRC remain unknown. In this study, we reveal that lncRNA FENDRR is downregulated in CRC and negatively correlated with advanced stage and poor clinical outcomes of patient with CRC. Overexpression of FENDRR represses the proliferation, migrate and invasive capacities of CRC cell in vitro, and upregulation of FENDRR inhibits the growth and distant metastatic capacity of CRC cell in vivo. Mechanistically, FENDRR interacts with miRNA-18a-5p (miR-18a-5p) and subsequently regulates the expression of inhibitor of growth 4 (ING4) in CRC cell. Interestingly, ING4 repression or miR-18a-5p rescues FENDRR induced proliferation and aggressive phenotypes inhibition of CRC cell. Altogether, our findings suggest that FENDRR exerts an inhibitory role in CRC by interacting with miR-18a-5p and future increases ING4 expression.
Insights
Long non-coding RNA FENDRR is downregulated in colorectal cancer (CRC), suppressing tumor growth and metastasis. It functions by interacting with miR-18a-5p to regulate ING4 expression, offering potential therapeutic strategies for CRC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer development.
- The specific involvement and clinical significance of FENDRR in colorectal cancer (CRC) remain largely unexplored.
Purpose of the Study:
- To investigate the role and mechanism of lncRNA FENDRR in colorectal cancer (CRC).
- To determine the correlation between FENDRR expression and clinical outcomes in CRC patients.
Main Methods:
- Quantitative real-time PCR to assess FENDRR and ING4 expression.
- In vitro cell proliferation, migration, and invasion assays.
- In vivo tumor growth and metastasis models.
- RNA immunoprecipitation and dual-luciferase reporter assays to confirm molecular interactions.
Main Results:
- FENDRR expression is significantly downregulated in CRC tissues and inversely correlated with advanced stage and poor prognosis.
- Overexpression of FENDRR inhibits CRC cell proliferation, migration, and invasion in vitro, and suppresses tumor growth and metastasis in vivo.
- FENDRR directly interacts with miR-18a-5p, leading to the downregulation of ING4 expression. Restoration of ING4 or inhibition of miR-18a-5p can rescue FENDRR's tumor-suppressive effects.
Conclusions:
- FENDRR acts as a tumor suppressor in colorectal cancer.
- The FENDRR/miR-18a-5p/ING4 axis plays a critical role in regulating CRC progression.
- FENDRR may serve as a potential diagnostic biomarker and therapeutic target for colorectal cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Experimental RNAi
Abnormal Proliferation